SGP SpyGlass Pharma, Inc.
Price Chart
Executive Summary
HC Wainwright initiated coverage on SGP with a Buy rating and $37 price target, joining four other firms that initiated Buy/Outperform ratings over the past week. The current share price is $25.20, implying 46.4% upside to the target. Consensus price target stands at $45 (mean) with a median of $42 and a high of $62, indicating HC Wainwright's target is below average. The firm has a 43% accuracy rate on 4,605 rated stocks, below the typical tier-one firm. All five recent actions were initiations, with no upgrades or downgrades in the past 30 days. EPS estimates remain negative across all periods, with no recent revisions. No earnings date is scheduled within 30 days.
Impact Score
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-03-10 | HC Wainwright & Co. | initiate | Buy | — |
| 2026-03-03 | Citigroup | initiate | Buy | — |
| 2026-03-03 | Leerink Partners | initiate | Outperform | — |
| 2026-03-03 | Jefferies | initiate | Buy | — |
| 2026-03-03 | Stifel | initiate | Buy | — |
There have been 5 initiations and 0 upgrades or downgrades in the past 30 days, representing a cluster initiation event. EPS revisions are flat: 0 revisions up and 0 down over the past 7 and 30 days. Current EPS estimates are negative: -$2.03 for 2026 and -$1.48 for 2027, with no improvement trend.
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1y | $-1.48 | $-1.78 — $-1.19 | $0.00 | ↑0 ↓0 |
| 0y | $-2.03 | $-2.52 — $-1.53 | $0.00 | ↑0 ↓0 |
| +1q | $-0.28 | $-0.32 — $-0.23 | $0.00 | ↑0 ↓0 |
| 0q | $-0.48 | $-0.48 — $-0.48 | $0.00 | ↑0 ↓0 |
Actionable Insight
The initiation cluster reflects growing analyst attention but lacks earnings catalysts or estimate momentum. Traders should monitor for follow-up coverage and volume expansion, but avoid aggressive positioning until price action confirms sentiment.
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 24, 2026
19d ago
|
ANALYST-UPGRADE
| $26.82 $27.20 | ▲ +1.42% | ▲ +2.32% | $18.44 (−31.25%) |
|
May 14, 2026
29d ago
|
8-K
| $23.21 $20.84 | ▼ −10.21% | ▼ −11.17% | $18.44 (−20.55%) |
|
Apr 16, 2026
8w ago
|
ANALYST-UPGRADE
| $24.94 $23.52 | ▼ −5.69% | ▼ −6.25% | $18.44 (−26.06%) |
|
Mar 26, 2026
11w ago
|
Press Release
| $22.61 $22.65 | ▲ +0.18% | ▼ −3.69% | $18.44 (−18.44%) |
|
Mar 9, 2026
13w ago
|
Press Release
| $27.12 $27.10 | ▼ −0.07% | ▲ +1.28% | $18.44 (−32.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access